| 1 | glycemic | 3,869 |
| 2 | glycaemic | 1,755 |
| 3 | lipemic | 13 |
| 4 | ginseol | 8 |
| 5 | t-reg | 7 |
| 6 | placebo-acupuncture | 5 |
| 7 | satin | 5 |
| 8 | souring | 5 |
| 9 | less-tight | 4 |
| 10 | neurotypical | 4 |
| 11 | observation/deferred | 4 |
| 12 | starling-like | 4 |
| 13 | triglyceridemic | 4 |
| 14 | arm-trunk | 3 |
| 15 | frontolimbic | 3 |
| 16 | placebo/no-intervention | 3 |
| 17 | process/pcr | 3 |
| 18 | shewhart | 3 |
| 19 | 'job | 2 |
| 20 | /glycemic | 2 |
| 21 | 1-microg/kg | 2 |
| 22 | 3-year-local | 2 |
| 23 | adra2a/taar1 | 2 |
| 24 | butter-based | 2 |
| 25 | fio2-spo2 | 2 |
| 26 | glyceamic | 2 |
| 27 | had-cmv | 2 |
| 28 | h─s | 2 |
| 29 | ianthodon | 2 |
| 30 | interdevice | 2 |
| 31 | noninotrope-based | 2 |
| 32 | nonneuropathy | 2 |
| 33 | ph-feedback | 2 |
| 34 | physical-performance | 2 |
| 35 | radioscopic | 2 |
| 36 | regiochemical | 2 |
| 37 | rq-feedback | 2 |
| 38 | tolerance/behavioral | 2 |
| 39 | ttbd | 2 |
| 40 | unmedicated-uninfected | 2 |
| 41 | 'photosynthetic | 1 |
| 42 | 'shock | 1 |
| 43 | 'wanted | 1 |
| 44 | 0-activity | 1 |
| 45 | 1/530 | 1 |
| 46 | 10-year-older | 1 |
| 47 | 100-kv/m | 1 |
| 48 | 11.2±1.1 | 1 |
| 49 | 13,817 | 1 |
| 50 | 19,070 | 1 |
| 51 | 19,554 | 1 |
| 52 | 1½-hour | 1 |
| 53 | 200-kv/m | 1 |
| 54 | 3,418 | 1 |
| 55 | 31,395 | 1 |
| 56 | 3158 | 1 |
| 57 | 33,689 | 1 |
| 58 | 40,779 | 1 |
| 59 | 48,324 | 1 |
| 60 | 55,367 | 1 |
| 61 | 64,762 | 1 |
| 62 | 7-item-asthma | 1 |
| 63 | 7596 | 1 |
| 64 | 7796 | 1 |
| 65 | 82054 | 1 |
| 66 | 8889 | 1 |
| 67 | 94,620 | 1 |
| 68 | abts*+ | 1 |
| 69 | act-asma | 1 |
| 70 | aero-phonatory | 1 |
| 71 | agent-free | 1 |
| 72 | analoguous | 1 |
| 73 | antibacterial-free | 1 |
| 74 | antimicrobian | 1 |
| 75 | arch-bars | 1 |
| 76 | assignments/passive | 1 |
| 77 | astma | 1 |
| 78 | atlas/infection | 1 |
| 79 | att-20-xenografted | 1 |
| 80 | attention/impulse | 1 |
| 81 | autovent-6 | 1 |
| 82 | biological/chemical/mechanical | 1 |
| 83 | bp/glycemic | 1 |
| 84 | carcinologic | 1 |
| 85 | cdss-based | 1 |
| 86 | cessation-focussed | 1 |
| 87 | challenge-unmedicated | 1 |
| 88 | cho/fat | 1 |
| 89 | citrate-locking-solution | 1 |
| 90 | clinicoroent-genologic | 1 |
| 91 | coagulologic | 1 |
| 92 | cohort/case | 1 |
| 93 | comorbidity-matched | 1 |
| 94 | computer-contact | 1 |
| 95 | computer-games | 1 |
| 96 | control-versus-rhythm | 1 |
| 97 | control/double | 1 |
| 98 | cortical/cognitive | 1 |
| 99 | cufoff | 1 |
| 100 | daily-event-writing | 1 |
| 101 | difficult-to | 1 |
| 102 | dose-tumor | 1 |
| 103 | dose-tumour | 1 |
| 104 | double-simulation | 1 |
| 105 | ea+diet | 1 |
| 106 | emg-spectral | 1 |
| 107 | endocrine-alone | 1 |
| 108 | epidemiologically-based | 1 |
| 109 | exercise-attention | 1 |
| 110 | fated | 1 |
| 111 | feedback-to-feedforward | 1 |
| 112 | forelimb- | 1 |
| 113 | grains-based | 1 |
| 114 | gycemic | 1 |
| 115 | gylcaemic | 1 |
| 116 | health-behaviours | 1 |
| 117 | hemarheological | 1 |
| 118 | hematuric | 1 |
| 119 | homestead- | 1 |
| 120 | ifn-α/β-mediated | 1 |
| 121 | induction-positive | 1 |
| 122 | infected-unmedicated | 1 |
| 123 | infusion-and-output | 1 |
| 124 | insulin-infused | 1 |
| 125 | iso-proteinaceous | 1 |
| 126 | kdoqi™ | 1 |
| 127 | l4440 | 1 |
| 128 | laboratory-analyzed | 1 |
| 129 | low-cf | 1 |
| 130 | management/emotional | 1 |
| 131 | manuring | 1 |
| 132 | mastitis-negative | 1 |
| 133 | minus-active | 1 |
| 134 | multirobot | 1 |
| 135 | n=2871 | 1 |
| 136 | niacin-placebo | 1 |
| 137 | no-constraint | 1 |
| 138 | no-milk | 1 |
| 139 | no-placebo | 1 |
| 140 | no-treatment/placebo | 1 |
| 141 | non-arginine-containing | 1 |
| 142 | non-do-not-resuscitate | 1 |
| 143 | non-gh-treated | 1 |
| 144 | non-homeless | 1 |
| 145 | non-neurofeedback | 1 |
| 146 | non-novel | 1 |
| 147 | non-rinsed | 1 |
| 148 | non-taped | 1 |
| 149 | non-verbalization | 1 |
| 150 | nonbacteriuria | 1 |
| 151 | nonencouraged | 1 |
| 152 | nonmolted | 1 |
| 153 | nonmusic-treated | 1 |
| 154 | nonpsychopathic | 1 |
| 155 | o-injected | 1 |
| 156 | oppp | 1 |
| 157 | parallel-active | 1 |
| 158 | patients-the | 1 |
| 159 | permit-required | 1 |
| 160 | phototropins | 1 |
| 161 | physiological/hormonal | 1 |
| 162 | placeb-parallel | 1 |
| 163 | placebo-glycine | 1 |
| 164 | placebo/positive | 1 |
| 165 | placebotreated | 1 |
| 166 | plant-disease | 1 |
| 167 | platform-based | 1 |
| 168 | polyethylene-wrap | 1 |
| 169 | postitive | 1 |
| 170 | postpdpr | 1 |
| 171 | powerpoint/active | 1 |
| 172 | practice-only | 1 |
| 173 | pre-exchange | 1 |
| 174 | premotoneuronal | 1 |
| 175 | preoperative-level | 1 |
| 176 | preplanting | 1 |
| 177 | propylthiouracil-fed | 1 |
| 178 | proteosynthesis | 1 |
| 179 | provider/system | 1 |
| 180 | pubs-negative | 1 |
| 181 | pullorum-challenged | 1 |
| 182 | pyrethroid-based | 1 |
| 183 | randomi*ed | 1 |
| 184 | rhizaria | 1 |
| 185 | saku | 1 |
| 186 | sham-electroporated | 1 |
| 187 | sk-mediated | 1 |
| 188 | solvent-only | 1 |
| 189 | spectacle-wearing | 1 |
| 190 | sperm-binding | 1 |
| 191 | spondyloarthritic | 1 |
| 192 | symtom | 1 |
| 193 | tg-raising | 1 |
| 194 | ti-free | 1 |
| 195 | transcriptional/translational | 1 |
| 196 | treatment/wait-list | 1 |
| 197 | trial.glycaemic | 1 |
| 198 | u.s.-marketed | 1 |
| 199 | unoperated-on | 1 |
| 200 | v3-trigeminal | 1 |
| 201 | volume-assist | 1 |
| 202 | within-monitor | 1 |
| 203 | δph-dependent | 1 |
| 1 | 'job | 2 |
| 2 | 'photosynthetic | 1 |
| 3 | 'shock | 1 |
| 4 | 'wanted | 1 |
| 5 | /glycemic | 2 |
| 6 | 0-activity | 1 |
| 7 | 1-microg/kg | 2 |
| 8 | 1/530 | 1 |
| 9 | 10-year-older | 1 |
| 10 | 100-kv/m | 1 |
| 11 | 11.2±1.1 | 1 |
| 12 | 13,817 | 1 |
| 13 | 19,070 | 1 |
| 14 | 19,554 | 1 |
| 15 | 1½-hour | 1 |
| 16 | 200-kv/m | 1 |
| 17 | 3,418 | 1 |
| 18 | 3-year-local | 2 |
| 19 | 31,395 | 1 |
| 20 | 3158 | 1 |
| 21 | 33,689 | 1 |
| 22 | 40,779 | 1 |
| 23 | 48,324 | 1 |
| 24 | 55,367 | 1 |
| 25 | 64,762 | 1 |
| 26 | 7-item-asthma | 1 |
| 27 | 7596 | 1 |
| 28 | 7796 | 1 |
| 29 | 82054 | 1 |
| 30 | 8889 | 1 |
| 31 | 94,620 | 1 |
| 32 | abts*+ | 1 |
| 33 | act-asma | 1 |
| 34 | adra2a/taar1 | 2 |
| 35 | aero-phonatory | 1 |
| 36 | agent-free | 1 |
| 37 | analoguous | 1 |
| 38 | antibacterial-free | 1 |
| 39 | antimicrobian | 1 |
| 40 | arch-bars | 1 |
| 41 | arm-trunk | 3 |
| 42 | assignments/passive | 1 |
| 43 | astma | 1 |
| 44 | atlas/infection | 1 |
| 45 | att-20-xenografted | 1 |
| 46 | attention/impulse | 1 |
| 47 | autovent-6 | 1 |
| 48 | biological/chemical/mechanical | 1 |
| 49 | bp/glycemic | 1 |
| 50 | butter-based | 2 |
| 51 | carcinologic | 1 |
| 52 | cdss-based | 1 |
| 53 | cessation-focussed | 1 |
| 54 | challenge-unmedicated | 1 |
| 55 | cho/fat | 1 |
| 56 | citrate-locking-solution | 1 |
| 57 | clinicoroent-genologic | 1 |
| 58 | coagulologic | 1 |
| 59 | cohort/case | 1 |
| 60 | comorbidity-matched | 1 |
| 61 | computer-contact | 1 |
| 62 | computer-games | 1 |
| 63 | control-versus-rhythm | 1 |
| 64 | control/double | 1 |
| 65 | cortical/cognitive | 1 |
| 66 | cufoff | 1 |
| 67 | daily-event-writing | 1 |
| 68 | difficult-to | 1 |
| 69 | dose-tumor | 1 |
| 70 | dose-tumour | 1 |
| 71 | double-simulation | 1 |
| 72 | ea+diet | 1 |
| 73 | emg-spectral | 1 |
| 74 | endocrine-alone | 1 |
| 75 | epidemiologically-based | 1 |
| 76 | exercise-attention | 1 |
| 77 | fated | 1 |
| 78 | feedback-to-feedforward | 1 |
| 79 | fio2-spo2 | 2 |
| 80 | forelimb- | 1 |
| 81 | frontolimbic | 3 |
| 82 | ginseol | 8 |
| 83 | glycaemic | 1,755 |
| 84 | glyceamic | 2 |
| 85 | glycemic | 3,869 |
| 86 | grains-based | 1 |
| 87 | gycemic | 1 |
| 88 | gylcaemic | 1 |
| 89 | had-cmv | 2 |
| 90 | health-behaviours | 1 |
| 91 | hemarheological | 1 |
| 92 | hematuric | 1 |
| 93 | homestead- | 1 |
| 94 | h─s | 2 |
| 95 | ianthodon | 2 |
| 96 | ifn-α/β-mediated | 1 |
| 97 | induction-positive | 1 |
| 98 | infected-unmedicated | 1 |
| 99 | infusion-and-output | 1 |
| 100 | insulin-infused | 1 |
| 101 | interdevice | 2 |
| 102 | iso-proteinaceous | 1 |
| 103 | kdoqi™ | 1 |
| 104 | l4440 | 1 |
| 105 | laboratory-analyzed | 1 |
| 106 | less-tight | 4 |
| 107 | lipemic | 13 |
| 108 | low-cf | 1 |
| 109 | management/emotional | 1 |
| 110 | manuring | 1 |
| 111 | mastitis-negative | 1 |
| 112 | minus-active | 1 |
| 113 | multirobot | 1 |
| 114 | n=2871 | 1 |
| 115 | neurotypical | 4 |
| 116 | niacin-placebo | 1 |
| 117 | no-constraint | 1 |
| 118 | no-milk | 1 |
| 119 | no-placebo | 1 |
| 120 | no-treatment/placebo | 1 |
| 121 | non-arginine-containing | 1 |
| 122 | non-do-not-resuscitate | 1 |
| 123 | non-gh-treated | 1 |
| 124 | non-homeless | 1 |
| 125 | non-neurofeedback | 1 |
| 126 | non-novel | 1 |
| 127 | non-rinsed | 1 |
| 128 | non-taped | 1 |
| 129 | non-verbalization | 1 |
| 130 | nonbacteriuria | 1 |
| 131 | nonencouraged | 1 |
| 132 | noninotrope-based | 2 |
| 133 | nonmolted | 1 |
| 134 | nonmusic-treated | 1 |
| 135 | nonneuropathy | 2 |
| 136 | nonpsychopathic | 1 |
| 137 | o-injected | 1 |
| 138 | observation/deferred | 4 |
| 139 | oppp | 1 |
| 140 | parallel-active | 1 |
| 141 | patients-the | 1 |
| 142 | permit-required | 1 |
| 143 | ph-feedback | 2 |
| 144 | phototropins | 1 |
| 145 | physical-performance | 2 |
| 146 | physiological/hormonal | 1 |
| 147 | placeb-parallel | 1 |
| 148 | placebo-acupuncture | 5 |
| 149 | placebo-glycine | 1 |
| 150 | placebo/no-intervention | 3 |
| 151 | placebo/positive | 1 |
| 152 | placebotreated | 1 |
| 153 | plant-disease | 1 |
| 154 | platform-based | 1 |
| 155 | polyethylene-wrap | 1 |
| 156 | postitive | 1 |
| 157 | postpdpr | 1 |
| 158 | powerpoint/active | 1 |
| 159 | practice-only | 1 |
| 160 | pre-exchange | 1 |
| 161 | premotoneuronal | 1 |
| 162 | preoperative-level | 1 |
| 163 | preplanting | 1 |
| 164 | process/pcr | 3 |
| 165 | propylthiouracil-fed | 1 |
| 166 | proteosynthesis | 1 |
| 167 | provider/system | 1 |
| 168 | pubs-negative | 1 |
| 169 | pullorum-challenged | 1 |
| 170 | pyrethroid-based | 1 |
| 171 | radioscopic | 2 |
| 172 | randomi*ed | 1 |
| 173 | regiochemical | 2 |
| 174 | rhizaria | 1 |
| 175 | rq-feedback | 2 |
| 176 | saku | 1 |
| 177 | satin | 5 |
| 178 | sham-electroporated | 1 |
| 179 | shewhart | 3 |
| 180 | sk-mediated | 1 |
| 181 | solvent-only | 1 |
| 182 | souring | 5 |
| 183 | spectacle-wearing | 1 |
| 184 | sperm-binding | 1 |
| 185 | spondyloarthritic | 1 |
| 186 | starling-like | 4 |
| 187 | symtom | 1 |
| 188 | t-reg | 7 |
| 189 | tg-raising | 1 |
| 190 | ti-free | 1 |
| 191 | tolerance/behavioral | 2 |
| 192 | transcriptional/translational | 1 |
| 193 | treatment/wait-list | 1 |
| 194 | trial.glycaemic | 1 |
| 195 | triglyceridemic | 4 |
| 196 | ttbd | 2 |
| 197 | u.s.-marketed | 1 |
| 198 | unmedicated-uninfected | 2 |
| 199 | unoperated-on | 1 |
| 200 | v3-trigeminal | 1 |
| 201 | volume-assist | 1 |
| 202 | within-monitor | 1 |
| 203 | δph-dependent | 1 |
| 1 | abts*+ | 1 |
| 2 | forelimb- | 1 |
| 3 | homestead- | 1 |
| 4 | 94,620 | 1 |
| 5 | 1/530 | 1 |
| 6 | l4440 | 1 |
| 7 | 19,070 | 1 |
| 8 | 11.2±1.1 | 1 |
| 9 | n=2871 | 1 |
| 10 | adra2a/taar1 | 2 |
| 11 | 64,762 | 1 |
| 12 | fio2-spo2 | 2 |
| 13 | 48,324 | 1 |
| 14 | 82054 | 1 |
| 15 | 19,554 | 1 |
| 16 | 31,395 | 1 |
| 17 | autovent-6 | 1 |
| 18 | 7596 | 1 |
| 19 | 7796 | 1 |
| 20 | 13,817 | 1 |
| 21 | 55,367 | 1 |
| 22 | 3,418 | 1 |
| 23 | 3158 | 1 |
| 24 | 40,779 | 1 |
| 25 | 33,689 | 1 |
| 26 | 8889 | 1 |
| 27 | rhizaria | 1 |
| 28 | nonbacteriuria | 1 |
| 29 | 7-item-asthma | 1 |
| 30 | act-asma | 1 |
| 31 | astma | 1 |
| 32 | 'job | 2 |
| 33 | frontolimbic | 3 |
| 34 | coagulologic | 1 |
| 35 | clinicoroent-genologic | 1 |
| 36 | carcinologic | 1 |
| 37 | nonpsychopathic | 1 |
| 38 | glyceamic | 2 |
| 39 | gylcaemic | 1 |
| 40 | glycaemic | 1,755 |
| 41 | trial.glycaemic | 1 |
| 42 | gycemic | 1 |
| 43 | glycemic | 3,869 |
| 44 | /glycemic | 2 |
| 45 | bp/glycemic | 1 |
| 46 | triglyceridemic | 4 |
| 47 | lipemic | 13 |
| 48 | radioscopic | 2 |
| 49 | hematuric | 1 |
| 50 | 'photosynthetic | 1 |
| 51 | spondyloarthritic | 1 |
| 52 | ttbd | 2 |
| 53 | randomi*ed | 1 |
| 54 | propylthiouracil-fed | 1 |
| 55 | nonencouraged | 1 |
| 56 | pullorum-challenged | 1 |
| 57 | comorbidity-matched | 1 |
| 58 | non-taped | 1 |
| 59 | permit-required | 1 |
| 60 | observation/deferred | 4 |
| 61 | pyrethroid-based | 1 |
| 62 | noninotrope-based | 2 |
| 63 | platform-based | 1 |
| 64 | butter-based | 2 |
| 65 | grains-based | 1 |
| 66 | cdss-based | 1 |
| 67 | epidemiologically-based | 1 |
| 68 | non-rinsed | 1 |
| 69 | cessation-focussed | 1 |
| 70 | insulin-infused | 1 |
| 71 | infected-unmedicated | 1 |
| 72 | challenge-unmedicated | 1 |
| 73 | nonmusic-treated | 1 |
| 74 | non-gh-treated | 1 |
| 75 | placebotreated | 1 |
| 76 | fated | 1 |
| 77 | sk-mediated | 1 |
| 78 | ifn-α/β-mediated | 1 |
| 79 | sham-electroporated | 1 |
| 80 | unmedicated-uninfected | 2 |
| 81 | o-injected | 1 |
| 82 | u.s.-marketed | 1 |
| 83 | att-20-xenografted | 1 |
| 84 | nonmolted | 1 |
| 85 | 'wanted | 1 |
| 86 | laboratory-analyzed | 1 |
| 87 | feedback-to-feedforward | 1 |
| 88 | interdevice | 2 |
| 89 | physical-performance | 2 |
| 90 | ti-free | 1 |
| 91 | antibacterial-free | 1 |
| 92 | agent-free | 1 |
| 93 | pre-exchange | 1 |
| 94 | patients-the | 1 |
| 95 | starling-like | 4 |
| 96 | control/double | 1 |
| 97 | placebo-glycine | 1 |
| 98 | endocrine-alone | 1 |
| 99 | placebo-acupuncture | 5 |
| 100 | cohort/case | 1 |
| 101 | plant-disease | 1 |
| 102 | attention/impulse | 1 |
| 103 | non-do-not-resuscitate | 1 |
| 104 | assignments/passive | 1 |
| 105 | pubs-negative | 1 |
| 106 | mastitis-negative | 1 |
| 107 | parallel-active | 1 |
| 108 | minus-active | 1 |
| 109 | powerpoint/active | 1 |
| 110 | cortical/cognitive | 1 |
| 111 | induction-positive | 1 |
| 112 | placebo/positive | 1 |
| 113 | postitive | 1 |
| 114 | low-cf | 1 |
| 115 | cufoff | 1 |
| 116 | t-reg | 7 |
| 117 | 1-microg/kg | 2 |
| 118 | sperm-binding | 1 |
| 119 | non-arginine-containing | 1 |
| 120 | spectacle-wearing | 1 |
| 121 | manuring | 1 |
| 122 | souring | 5 |
| 123 | tg-raising | 1 |
| 124 | daily-event-writing | 1 |
| 125 | preplanting | 1 |
| 126 | ph-feedback | 2 |
| 127 | rq-feedback | 2 |
| 128 | non-neurofeedback | 1 |
| 129 | 'shock | 1 |
| 130 | no-milk | 1 |
| 131 | arm-trunk | 3 |
| 132 | hemarheological | 1 |
| 133 | regiochemical | 2 |
| 134 | biological/chemical/mechanical | 1 |
| 135 | neurotypical | 4 |
| 136 | 3-year-local | 2 |
| 137 | v3-trigeminal | 1 |
| 138 | transcriptional/translational | 1 |
| 139 | management/emotional | 1 |
| 140 | physiological/hormonal | 1 |
| 141 | premotoneuronal | 1 |
| 142 | tolerance/behavioral | 2 |
| 143 | emg-spectral | 1 |
| 144 | placeb-parallel | 1 |
| 145 | preoperative-level | 1 |
| 146 | non-novel | 1 |
| 147 | ginseol | 8 |
| 148 | 100-kv/m | 1 |
| 149 | 200-kv/m | 1 |
| 150 | provider/system | 1 |
| 151 | control-versus-rhythm | 1 |
| 152 | symtom | 1 |
| 153 | antimicrobian | 1 |
| 154 | satin | 5 |
| 155 | unoperated-on | 1 |
| 156 | ianthodon | 2 |
| 157 | double-simulation | 1 |
| 158 | non-verbalization | 1 |
| 159 | atlas/infection | 1 |
| 160 | exercise-attention | 1 |
| 161 | placebo/no-intervention | 3 |
| 162 | citrate-locking-solution | 1 |
| 163 | niacin-placebo | 1 |
| 164 | no-placebo | 1 |
| 165 | no-treatment/placebo | 1 |
| 166 | difficult-to | 1 |
| 167 | polyethylene-wrap | 1 |
| 168 | oppp | 1 |
| 169 | process/pcr | 3 |
| 170 | 10-year-older | 1 |
| 171 | dose-tumor | 1 |
| 172 | within-monitor | 1 |
| 173 | postpdpr | 1 |
| 174 | 1½-hour | 1 |
| 175 | dose-tumour | 1 |
| 176 | computer-games | 1 |
| 177 | proteosynthesis | 1 |
| 178 | phototropins | 1 |
| 179 | arch-bars | 1 |
| 180 | health-behaviours | 1 |
| 181 | non-homeless | 1 |
| 182 | iso-proteinaceous | 1 |
| 183 | analoguous | 1 |
| 184 | h─s | 2 |
| 185 | cho/fat | 1 |
| 186 | computer-contact | 1 |
| 187 | ea+diet | 1 |
| 188 | less-tight | 4 |
| 189 | δph-dependent | 1 |
| 190 | no-constraint | 1 |
| 191 | multirobot | 1 |
| 192 | shewhart | 3 |
| 193 | treatment/wait-list | 1 |
| 194 | volume-assist | 1 |
| 195 | infusion-and-output | 1 |
| 196 | saku | 1 |
| 197 | had-cmv | 2 |
| 198 | nonneuropathy | 2 |
| 199 | practice-only | 1 |
| 200 | solvent-only | 1 |
| 201 | aero-phonatory | 1 |
| 202 | 0-activity | 1 |
| 203 | kdoqi™ | 1 |